BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2018
View Archived Issues
Targeting Mdf could inhibit the evolution of antimicrobial resistance
Read More
Cation channel TRPV1 identified as a therapeutic target for cardiac hypertrophy and heart failure
Read More
RIP1 is an immune checkpoint kinase conferring immunotherapy resistance in pancreatic ductal cancer
Read More
BET bromodomain inhibitors destress ALS cells
Read More
Alpha-synuclein derails lipid metabolism
Read More
BCL6 unveiled as a novel therapeutic target for triple-negative breast cancer
Read More
BRG1-SOX4 drives oncogenic signaling in triple-negative breast cancer
Read More
CDC20 emerges as a novel target for triple-negative breast cancer
Read More
Metastasis of triple-negative breast cancer is controlled by PEA15 phosphorylation
Read More
In MDS and AML, many bad seeds
Read More
Vanda presents promising data from pivotal study of tasimelteon in Smith-Magenis syndrome
Read More
Phase II study of zilucoplan in gMG meets primary and key secondary endpoints
Read More
Phase II study of serlopitant demonstrates reduction of pruritus associated with psoriasis
Read More
Phase I study of silmitasertib shows promise in patients with cholangiocarcinoma
Read More
Oppilan Pharma presents sphingosine 1-phosphate receptor 1 agonists
Read More
LegoChem Biosciences patents E-NPP 2 inhibitors
Read More
WDR5/MLL1 interaction inhibitors identified at the University of Michigan
Read More
Prescient Therapeutics reports interim durability data on PTX-200 in breast cancer
Read More
Vanderbilt University synthesizes RAS GTPase inhibitors
Read More
Shionogi and Ube establish strategic research collaboration in RSV
Read More
Arctic Pharma discovers lactate dehydrogenase A inhibitors
Read More
Immix reports interim findings from phase Ib/IIa study of IMX-110 in advanced solid tumors
Read More
Itanapraced demonstrates animal proof of concept in Parkinson's disease models
Read More
Axovant reports exploratory phase II study results for nelotanserin
Read More
Marinus reports interim phase II data with intravenous and oral ganaxolone in postpartum depression
Read More
Constellation advances ProSTAR trial of CPI-1205 in metastatic CRPC into phase II
Read More
IDMC recommends continuation of phase II/III trial of AXS-05 in Alzheimer's disease agitation
Read More
Cantargia presents update on its CANFOUR study of CAN-04
Read More